The aberrant expression of TTN-AS1 played a key role of regulatory in the carcinogenesis of lung cancer, liver cancer, glioblastoma, and breast cancer (Wang et al., 2020a; Fang et al., 2020; Qi and Li, 2020; Tang et al., 2020). Here, TTN is linked to lung carcinoma.